Anti-inflammatory activity of curcumin-loaded solid lipid nanoparticles in IL-1β transgenic mice subjected to the lipopolysaccharide-induced sepsis
Tài liệu tham khảo
Cohen, 2002, The immunopathogenesis of sepsis, Nature, 420, 885, 10.1038/nature01326
Hotchkiss, 2003, The pathophysiology and treatment of sepsis, N Engl J Med, 348, 138, 10.1056/NEJMra021333
Wheeler, 2009, Death to sepsis: targeting apoptosis pathways in sepsis, Crit Care, 13, 1010, 10.1186/cc8162
Dellinger, 2008, Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008, Crit Care Med, 36, 296, 10.1097/01.CCM.0000298158.12101.41
Chowdhury, 2006, Toll-like receptors TLR2 and TLR4 initiate the innate immune response of the renal tubular epithelium to bacterial products, Clin Exp Immunol, 145, 346, 10.1111/j.1365-2249.2006.03116.x
Shi, 2014, Inflammatory caspases are innate immune receptors for intracellular LPS, Nature, 514, 187, 10.1038/nature13683
Salomao, 2012, Bacterial sensing, cell signaling, and modulation of the immune response during sepsis, Shock, 38, 227, 10.1097/SHK.0b013e318262c4b0
Maheshwari, 2006, Multiple biological activities of curcumin: a short review, Life Sci, 78, 2081, 10.1016/j.lfs.2005.12.007
Basnet, 2011, Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment, Molecules, 16, 4567, 10.3390/molecules16064567
Aggarwal, 2009, Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases, Int J Biochem Cell Biol, 41, 40, 10.1016/j.biocel.2008.06.010
Sompamit, 2009, Curcumin improves vascular function and alleviates oxidative stress in non-lethal lipopolysaccharide-inducedendotoxaemia in mice, Eur J Pharmacol, 616, 192, 10.1016/j.ejphar.2009.06.014
Poylin, 2008, The NF-kappaB inhibitor curcumin blocks sepsis-induced muscle proteolysis, Mediat Inflamm, 2008, 317851, 10.1155/2008/317851
Xiao, 2012, Curcumin protects against sepsis-induced acute lung injury in rats, J Surg Res, 176, e31, 10.1016/j.jss.2011.11.1032
Lukita-Atmadja, 2002, Effect of curcuminoids as anti-inflammatory agents on the hepatic microvascular response to endotoxin, Shock, 17, 399, 10.1097/00024382-200205000-00010
Yang, 2013, Protective effect of curcumin against cardiac dysfunction in sepsis rats, Pharm Biol, 51, 482, 10.3109/13880209.2012.742116
Gupta, 2011, Multitargeting by curcumin as revealed by molecular interaction studies, Nat Prod Rep, 28, 1937, 10.1039/c1np00051a
Anand, 2007, Bioavailability of curcumin: problems and promises, Mol Pharm, 4, 807, 10.1021/mp700113r
Burgos-Morón, 2010, The dark side of curcumin, Int J Cancer, 126, 1771
Mohanty, 2010, The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation, Biomaterials, 31, 6597, 10.1016/j.biomaterials.2010.04.062
Hou, 2003, The production and characteristics of solid lipid nanoparticles (SLNs), Biomaterials, 24, 1781, 10.1016/S0142-9612(02)00578-1
Mehnert, 2001, Solid lipid nanoparticles: production, characterization and applications, Adv Drug Deliv Rev, 47, 165, 10.1016/S0169-409X(01)00105-3
Gao, 2008, The role of daidzein-loaded sterically stabilized solid lipid nanoparticles in therapy for cardio-cerebrovascular diseases, Biomaterials, 29, 4129, 10.1016/j.biomaterials.2008.07.008
Xu, 2009, The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma, Biomaterials, 30, 226, 10.1016/j.biomaterials.2008.09.014
Kuo, 2011, Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor, Biomaterials, 32, 3340, 10.1016/j.biomaterials.2011.01.048
Wang, 2012, Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles, Int J Nanomedicine, 7, 3667, 10.2147/IJN.S30428
Wang, 2015, Intracellular uptake of etoposide-loaded solid lipid nanoparticles induces an enhancing inhibitory effect on gastric cancer through mitochondria-mediated apoptosis pathway, J Biomed Nanotechnol, 11, 403, 10.1166/jbn.2015.1925
Li, 2008, Functional imaging of interleukin 1 beta expression in inflammatory process using bioluminescence imaging in transgenic mice, BMC Immunol, 9, 49, 10.1186/1471-2172-9-49
Li, 2013, Bioluminescence imaging for IL-1β expression in experimental colitis, J Inflamm, 10, 16
Li, 2009, Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles, J Control Release, 133, 238, 10.1016/j.jconrel.2008.10.002
Liu, 2014, Biocompatibility of silk-tropoelastin protein polymers, Biomaterials, 35, 5138, 10.1016/j.biomaterials.2014.03.024
Tavakoli, 2012, Interferon-γ deficiency reduces neointimal formation in a model of endoluminal endothelial injury combined with atherogenic diet, Int J Mol Med, 30, 545, 10.3892/ijmm.2012.1034
Li, 2010, Signalling pathways involved in the activation of dendritic cells by layered double hydroxide nanoparticles, Biomaterials, 31, 748, 10.1016/j.biomaterials.2009.09.095
Wang, 2014, The enhanced immune response of hepatitis B virus DNA vaccine using SiO2@LDH nanoparticles as an adjuvant, Biomaterials, 35, 466, 10.1016/j.biomaterials.2013.09.060
Morishige, 2010, The effect of surface modification of amorphous silica particles on NLRP3 inflammasome mediated IL-1beta production, ROS production and endosomal rupture, Biomaterials, 31, 6833, 10.1016/j.biomaterials.2010.05.036
Cannon, 1992, Circulating interleukin-1 beta and tumor necrosis factor-alpha concentrations after burn injury in humans, Crit Care Med, 20, 1414, 10.1097/00003246-199210000-00009
Akira, 2004, Toll-like receptor signalling, Nat Rev Immunol, 4, 499, 10.1038/nri1391
Akira, 2006, Pathogen recognition and innate immunity, Cell, 124, 783, 10.1016/j.cell.2006.02.015
Anonymous, 2012, Focus on sepsis, Nat Med, 18, 997, 10.1038/nm0712-997
O'Brien, 1992, Global surveillance of antibiotic resistance, N Engl J Med, 326, 339, 10.1056/NEJM199201303260510
Stoll, 2002, Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network, Pediatrics, 110, 285, 10.1542/peds.110.2.285
Andrews, 2006, Year in review in intensive care medicine, 2005. II. Infection and sepsis, ventilator associated pneumonia, ethics, hematology and hemostasis, ICU organization and scoring, brain injury, Intensive Care Med, 32, 380, 10.1007/s00134-005-0060-y
Singh, 2007, From exotic spice to modern drug?, Cell, 130, 765, 10.1016/j.cell.2007.08.024
Srivastava, 1985, Anti-thrombotic effect of curcumin, Thromb Res, 40, 413, 10.1016/0049-3848(85)90276-2
Shin, 2011, Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism, Mol Nutr Food Res, 55, 1829, 10.1002/mnfr.201100440
Asai, 2001, Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue, J Nutr, 131, 2932
Baum, 2004, Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models, J Alzheimers Dis, 6, 367, 10.3233/JAD-2004-6403
Hanai, 2009, Curcumin has bright prospects for the treatment of inflammatory bowel disease, Curr Pharm Des, 15, 2087, 10.2174/138161209788489177
Aggarwal, 2009, Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets, Trends Pharmacol Sci, 30, 85, 10.1016/j.tips.2008.11.002
Naksuriya, 2014, Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment, Biomaterials, 3, 3365, 10.1016/j.biomaterials.2013.12.090
Fang, 2011, The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect, Adv Drug Deliv Rev, 63, 136, 10.1016/j.addr.2010.04.009
Kim, 2012, Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials, Biomaterials, 33, 1838, 10.1016/j.biomaterials.2011.11.020
Strehle, 2009, Long-term management of children with neuromuscular disorders, J Pediatr (Rio J), 85, 379, 10.2223/JPED.1929
Netea, 2003, Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing?, Trends Immunol, 24, 254, 10.1016/S1471-4906(03)00079-6
Ulloa, 2005, The “cytokine profile”: a code for sepsis, Trends Mol Med, 11, 56, 10.1016/j.molmed.2004.12.007
Chen, 2013, Ulinastatin reduces urinary sepsis-related inflammation by upregulating IL-10 and downregulating TNF-α levels, Mol Med Rep, 8, 29, 10.3892/mmr.2013.1480
Drazan, 1996, Viral IL-10 gene therapy inhibits TNF-alpha and IL-1 beta, not IL-6, in the newborn endotoxemic mouse, J Pediatr Surg, 31, 411, 10.1016/S0022-3468(96)90749-6
Scumpia, 2005, Biology of interleukin-10 and its regulatory roles in sepsis syndromes, Crit Care Med, 33, S468, 10.1097/01.CCM.0000186268.53799.67
Gower, 2014, Modulation of leukocyte infiltration and phenotype in microporous tissue engineering scaffolds via vector induced IL-10 expression, Biomaterials, 35, 2024, 10.1016/j.biomaterials.2013.11.036
Goldstein, 2005, International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics, Pediatr Crit Care Med, 6, 2, 10.1097/01.PCC.0000149131.72248.E6
Rhee, 2000, Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase, J Biol Chem, 275, 34035, 10.1074/jbc.M007386200
Spiller, 2008, TLR4-induced IFN-gamma production increases TLR2 sensitivity and drives Gram-negative sepsis in mice, J Exp Med, 205, 1747, 10.1084/jem.20071990
Gadjeva, 2004, A role for NF-kappa B subunits p50 and p65 in the inhibition of lipopolysaccharide-induced shock, J Immunol, 173, 5786, 10.4049/jimmunol.173.9.5786
Buchanan, 2009, Patient sex and its influence on general anaesthesia, Anaesth Intensive Care, 37, 207, 10.1177/0310057X0903700201
Jarugula, 2010, Influence of body weight and gender on the pharmacokinetics, pharmacodynamics, and antihypertensive efficacy of aliskiren, J Clin Pharmacol, 50, 1358, 10.1177/0091270009359525